Clinical Trials
3 trialsNCT01188252 2017-01-09
Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced Malignancies
Bayer
Phase 1 Completed
NCT02390154 2016-07-15
Roniciclib Mass Balance Study
Bayer
Phase 1 Completed
NCT02457351 2016-05-23
Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) Study
Bayer
Phase 1 Completed